EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Calcitriol–PKM2 axis drives transcriptional and metabolic reprogramming of ILCPs into intestinal dual-cytokine-producing ILC3s

Qingyang Liu iD, Yidan Wang, Yanxiu Li, Yiyan Wang, Wei Liu, Steven Rosen iD, Fang Liang, Tingting Xie, Yang Xia iD

Proceedings of the National Academy of Sciences · 04.08.2026 · 123 (31)

DOI: 10.1073/pnas.2600260123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 28.07.2026. Verfasst von Qingyang Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China. Hauptthemen laut MEDLINE: Calcitriol, Lymphocytes, Pyruvate Kinase, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitamin D deficiency is associated with dysregulated alloimmune responses, but the mechanisms by which its active metabolite calcitriol shapes innate lymphoid cell (ILC) development and function remain incompletely understood. Here, we elucidate how calcitriol directs the differentiation of bone marrow (BM) ILC progenitors (ILCPs) into anti-inflammatory ILC3s with therapeutic potential in alloimmune diseases. Using murine vitamin D models, integrated omics, 13 C-glucose tracing, humanized mouse models, and clinical samples, we show that calcitriol, through the vitamin D receptor (VDR), selectively promotes the expansion and differentiation of BM ILCPs into IL-10 + IL-22 + ILC3s that exert tissue-protective effects in the intestine. Calcitriol-primed BM ILCP cell therapy attenuates intestinal inflammation in an alloimmune setting. Mechanistically, a VDR–SYK axis triggers nuclear translocation of pyruvate kinase M2 (PKM2). Nuclear PKM2 phosphorylates STAT3 at Tyr705, forming a dimerization complex with c-JUN that drives Il10 transcription. Simultaneously, cytosolic PKM2 channels pyruvate into pyruvate carboxylase–mediated mitochondrial anaplerosis, sustaining oxidative phosphorylation while suppressing reverse electron transport-driven mitochondrial ROS production. In human studies, patients with severe alloimmune complications exhibit reduced circulating ILCPs and low serum 25(OH)D levels. Calcitriol-treated human CD117 + ILCPs efficiently generate IL-10-producing ILCs in vitro and in humanized models, potently suppressing alloreactive T cell responses. Collectively, calcitriol reprograms BM ILCPs via the VDR–SYK–PKM2 axis to generate dual-cytokine IL-10 + IL-22 + ILC3s, establishing PKM2 as a key immunometabolic target and supporting calcitriol-primed ILCP-based cell therapy as a promising approach for alloimmune diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CalcitriolLymphocytesPyruvate KinaseMembrane ProteinsAnimalsMiceHumansMetabolic ReprogrammingCell DifferentiationImmunity, InnateCytokinesInterleukin-10Receptors, CalcitriolInterleukin-22IntestinesThyroid Hormone-Binding ProteinsInterleukins

Stichwörter der Autor:innen

PKM2alloimmune responsescell therapyimmunometabolisminnate lymphoid cells

Substanzen

CalcitriolPyruvate KinasePkm protein, mouseCytokinesInterleukin-10Receptors, CalcitriolInterleukin-22Membrane ProteinsThyroid Hormone-Binding ProteinsInterleukins

Autor:innen und Institutionen

  • Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • National Medical Metabolomics International Collaborative Research Center, Central South University, Changsha, Hunan 410008, China.
  • National Clinical Research Center for Geriatric Disease, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Department of Otolaryngology-Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
  • Hunan Key Laboratory of Ophthalmology, Central South University, Changsha, Hunan 410008, China.
  • Eye Center, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.

ORCID-Profile: Qingyang Liu, Steven Rosen, Yang Xia

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)

Zitieren

APA

Liu, Q., Wang, Y., Li, Y., Wang, Y., Liu, W., Rosen, S., Liang, F., Xie, T., & Xia, Y. (2026). Calcitriol–PKM2 axis drives transcriptional and metabolic reprogramming of ILCPs into intestinal dual-cytokine-producing ILC3s. Proceedings of the National Academy of Sciences, 123(31). https://doi.org/10.1073/pnas.2600260123

Vancouver

Liu Q, Wang Y, Li Y, Wang Y, Liu W, Rosen S, et al. Calcitriol–PKM2 axis drives transcriptional and metabolic reprogramming of ILCPs into intestinal dual-cytokine-producing ILC3s. Proceedings of the National Academy of Sciences. 2026;123(31). doi:10.1073/pnas.2600260123

BibTeX
@article{Liu2026,
  author = {Liu, Qingyang and Wang, Yidan and Li, Yanxiu and Wang, Yiyan and Liu, Wei and Rosen, Steven and Liang, Fang and Xie, Tingting and Xia, Yang},
  title = {Calcitriol–PKM2 axis drives transcriptional and metabolic reprogramming of ILCPs into intestinal dual-cytokine-producing ILC3s},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  volume = {123},
  number = {31},
  doi = {10.1073/pnas.2600260123}
}
Kostenlos starten →